GSTM1 and prostate carcinoma: Another meta-analysis by Gong and co-workers 2012 showed a significant association of GSTM1 polymorphism with the risk of prostate cancer; however, it did not find such correlations for the GSTT1 and GSTP1 deletions, thus confirming the results of Mo and co-workers 2009.